Hernandez v. Mimi's Rock Corp.

Background

Alfredo Hernandez filed a putative class action against DTI GmbH concerning DTI’s Dr. Tobias Omega 3 Fish Oil Triple Strength dietary supplement. Hernandez alleged that the product was not properly identified as “fish oil” because it contained omega-3 fatty acid ethyl esters produced through a chemical process, rather than omega-3 fatty acids in their natural triglyceride form. He claimed that this labeling deceived consumers and interfered with informed purchasing decisions.

The second amended complaint asserted seven causes of action: unlawful, unfair, and fraudulent business practices under California’s Unfair Competition Law; false advertising under California’s False Advertising Law; violations of the Consumers Legal Remedies Act; breach of express warranty; and restitution based on quasi-contract and unjust enrichment. Hernandez also sought class certification and related class-representative relief. DTI moved to dismiss under Federal Rule of Civil Procedure 12(b)(6), which tests whether a complaint states a legally sufficient claim, and Rule 12(b)(1), which tests subject-matter jurisdiction.

Materials and Legal Standards

The court granted DTI’s request for judicial notice of excerpts from the Food and Drug Administration’s Food Labeling Guide. It also considered documents Hernandez cited extensively in his complaint under the incorporation-by-reference doctrine. The court explained that, at the pleading stage, it generally accepts factual allegations as true and views them in the light most favorable to the plaintiff, but it need not accept allegations contradicted by documents incorporated into the complaint.

Standing for Equitable and Injunctive Relief

The court dismissed Hernandez’s request for equitable relief with leave to amend because he did not allege that he lacked an adequate legal remedy. The court rejected DTI’s argument that Hernandez lacked standing to seek injunctive relief. Hernandez alleged that he would consider purchasing the product in the future if its labeling became truthful and non-deceptive. The court found that allegation sufficient and denied DTI’s motion to dismiss the request for injunctive relief for lack of standing.

Preemption

DTI argued that federal food-labeling law expressly preempted Hernandez’s claims because the state-law theory would impose labeling requirements different from federal requirements. DTI also argued that state and federal requirements conflicted. The court rejected both arguments at this stage. It concluded that the product’s “common or usual name” had not been definitively established and that the materials before the court did not resolve whether “fish oil” could describe an omega-3 fatty acid ethyl ester product. The court therefore found that Hernandez’s claims were not expressly or conflict-preempted.

Reasonable Consumer Claims

The court then reached DTI’s argument that the label could not deceive a reasonable consumer. Under the California Unfair Competition Law, False Advertising Law, and Consumers Legal Remedies Act, a plaintiff must plausibly allege that a reasonable consumer is likely to be misled.

The court held that Hernandez had not plausibly alleged that a reasonable consumer would expect an omega-3 supplement labeled “fish oil” to disclose whether its EPA and DHA were attached to a glycerol backbone or an ethanol backbone. Although the court recognized that molecular differences existed between the triglyceride and ethyl-ester forms, it found no factual allegations showing that average consumers considered those molecular distinctions when purchasing fish-oil-derived omega-3 products. The court therefore dismissed the Unfair Competition Law, False Advertising Law, and Consumers Legal Remedies Act claims with leave to amend.

Because the express-warranty and unjust-enrichment claims were also based on the allegedly false or misleading labeling, the court dismissed those claims with leave to amend as well.

Other Labeling Claims

The court dismissed with prejudice Hernandez’s claim that DTI was required to list every constituent of a dietary ingredient in the supplement facts panel. It concluded that the applicable regulation allows, but does not require, constituents of a dietary ingredient to be listed.

The court also dismissed with prejudice Hernandez’s claim that the supplement facts panel was false or misleading because it listed EPA and DHA. The court concluded that constituents not required to appear in the panel need not be listed by their common or usual names.

Finally, the court dismissed with prejudice the claim concerning the product’s “Triple Strength” statement. The regulation Hernandez relied on applies when a statement compares the amount of a dietary ingredient with the amount in a specified reference food. Because the product label did not identify a reference food, and because Hernandez identified no other law requiring DTI to identify a comparable product, the court found the “Triple Strength” claim neither vague nor misleading. The court concluded that amendment would be futile.

Disposition

The court denied in part and granted in part DTI’s motion to dismiss. It dismissed the equitable-relief request, the California consumer-protection claims, and the express-warranty and unjust-enrichment claims with leave to amend. It dismissed with prejudice the claims concerning the ingredient list, the supplement facts panel, and the “Triple Strength” statement. Hernandez was allowed 28 days to file an amended complaint solely to cure the deficiencies identified in the order; otherwise, the order states that his claims would be dismissed with prejudice.